MarketPeel
Insider Trading Intelligence
MM

Meredith Manning

SLNO
CHIEF COMMERCIAL OFFICER · SOLENO THERAPEUTICS INC · CIK 0001752631
FILING MIX · LIFETIME25%/75%
BUYS
6
SELLS
18
TOTAL VALUE
$5.08M
COMPANIES
1
ACTIVE SINCE
Jul 2024
HOLDINGS NOW
0
AVG SELL PX
$61.60
TRADE KIND
SHOWING 24 / 24
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Meredith Manning, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+0.00%+13.16%-3.16%+16.32%+12.44%
14d12+75.00%+13.76%-3.83%+17.59%+0.79%
30d12+0.00%+25.42%+1.02%+24.40%+11.61%
60d12+0.00%+13.16%+4.25%+8.92%+8.92%
90d12+0.00%+27.30%+9.21%+20.24%+20.24%
180d12(3 pending)+100.00%-15.64%+16.95%-32.59%-32.59%
1y12(3 pending)+100.00%-55.41%+11.82%-67.22%-67.22%
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SLNO · 0 shares · as of May 18, 2026
022,75045,50068,25091,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 18 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
32,8000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
91,0000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
64,5070May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
29,2000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
558$31.72$17.7K64,507Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
4,864$30.04$146.1K67,165Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
2,100$31.04$65.2K65,065Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
28,60072,029Jan 21, 2026Jan 23, 2026View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
32,80032,800Jan 21, 2026Jan 23, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
1,922$49.95$96.0K43,429Dec 15, 2025Dec 17, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
225$71.74$16.1K45,385Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
34$72.64$2.5K45,351Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
37,00091,000Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
37,000$67.04$2.48M45,351Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
1,087$66.79$72.6K51,845Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
Chief Commercial Officer
37,000$46.31$1.71M82,351Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
668$65.97$44.1K52,932Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
2,599$68.79$178.8K47,270Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
1,505$69.84$105.1K45,765Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
155$70.73$11.0K45,610Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Chief Commercial Officer
1,976$67.70$133.8K49,869Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
29,20029,200Jan 21, 2025Jan 23, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
13,60053,600Jan 21, 2025Jan 23, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jul 17, 2024Jul 19, 2024View →
Other insiders · SLNO
Loading peer insiders…
About this filer
CIK 0001752631
ROLE
Chief Commercial Officer
PRIMARY
SLNO
COMPANIES
1
ACTIVE SINCE
Jul 2024
MARKETPEEL · /INSIDER/0001752631DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback